Premium support included In-app purchase unlocks advanced analytics, meal plans, Health Kit integration and VIP support
Rehan ST, Siddiqui AH, Khan Z, Imran L, Syed AA, Tahir MJ, et al
Based on the broader disease categories, the type 2 diabetes (T2DM) segment accounted for the largest share of the total market for GLP-1 receptor agonists (GLP-1 RAs), primarily due to the established use of these medications for diabetes management over a longer period, and the higher prevalence of T2DM
In addition to initial FLOW trial findings indicating Ozempic can offer kidney protective benefits, results of Novo Nordisks SELECT trial showed that semaglutide significantly reduced rates of kidney and cardiovascular events compared with placebo in participants with overweight and obesity with cardiovascular disease but without diabetes
The Federal Food, Drug, and Cosmetic Act establishes two categories of compounding facilities, each with different regulatory requirements
While statistically significant, this generally falls below the clinical significance threshold
